FI844230L - Enzyminhibition. - Google Patents

Enzyminhibition.

Info

Publication number
FI844230L
FI844230L FI844230A FI844230A FI844230L FI 844230 L FI844230 L FI 844230L FI 844230 A FI844230 A FI 844230A FI 844230 A FI844230 A FI 844230A FI 844230 L FI844230 L FI 844230L
Authority
FI
Finland
Prior art keywords
residue
proline
glycine
possibly
valine
Prior art date
Application number
FI844230A
Other languages
English (en)
Other versions
FI844230A0 (fi
FI88398C (fi
FI88398B (fi
Inventor
Michael Szelke
David Michael Jones
Martin Andrew Brydson
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of FI844230L publication Critical patent/FI844230L/fi
Publication of FI844230A0 publication Critical patent/FI844230A0/fi
Application granted granted Critical
Publication of FI88398B publication Critical patent/FI88398B/fi
Publication of FI88398C publication Critical patent/FI88398C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI844230A 1983-03-04 1984-10-29 Foerfarande foer framstaellning av peptidanaloger FI88398C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838305985A GB8305985D0 (en) 1983-03-04 1983-03-04 Enzyme inhibition
GB8305985 1983-03-04
GB8400063 1984-02-28
PCT/GB1984/000063 WO1984003507A1 (en) 1983-03-04 1984-02-28 Enzyme inhibition

Publications (4)

Publication Number Publication Date
FI844230L true FI844230L (fi) 1984-10-29
FI844230A0 FI844230A0 (fi) 1984-10-29
FI88398B FI88398B (fi) 1993-01-29
FI88398C FI88398C (fi) 1993-05-10

Family

ID=10538985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844230A FI88398C (fi) 1983-03-04 1984-10-29 Foerfarande foer framstaellning av peptidanaloger

Country Status (13)

Country Link
US (2) US4638047A (fi)
EP (1) EP0118280B1 (fi)
JP (1) JPS60500870A (fi)
AT (1) ATE44533T1 (fi)
AU (1) AU596783B2 (fi)
CA (1) CA1322078C (fi)
DE (1) DE3478928D1 (fi)
DK (1) DK520284A (fi)
ES (1) ES530262A0 (fi)
FI (1) FI88398C (fi)
GB (1) GB8305985D0 (fi)
IE (1) IE56958B1 (fi)
WO (1) WO1984003507A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4812442A (en) * 1984-05-29 1989-03-14 Merck & Co., Inc. Tripeptide renin inhibitors
DE3438545A1 (de) * 1984-10-20 1986-04-24 Merck Patent Gmbh, 6100 Darmstadt Peptide
DE3512128A1 (de) * 1985-04-03 1986-10-09 Merck Patent Gmbh, 6100 Darmstadt Peptide
US4705778A (en) * 1985-10-22 1987-11-10 Sri International Orally active LHRH analogs
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US4859654A (en) * 1987-07-01 1989-08-22 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US6313096B1 (en) 1988-04-28 2001-11-06 Trigen Limited Inhibitors of trypsin-like enzymes
US5574014A (en) * 1988-04-28 1996-11-12 Thrombosis Research Institute Inhibitors of trypsin-like enzymes
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
EP0462229A4 (en) * 1989-05-02 1992-03-11 Genelabs Incorporated Chemically modified cd4 peptide fragments having anti-retroviral properties
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
JP2669510B2 (ja) * 1990-06-15 1997-10-29 ナショナル・リサーチ・カウンシル・オブ カナダ ヒルジンのアミノ酸配列に基づくトロンビン阻害剤
ATE174603T1 (de) * 1991-02-04 1999-01-15 Akzo Nobel Nv Faktor iia inhibitoren
WO1993003748A1 (en) * 1991-08-13 1993-03-04 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
WO1994002505A1 (en) * 1992-07-20 1994-02-03 Duke University Compounds which inhibit hiv replication
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5637599A (en) * 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
GB9502985D0 (en) * 1995-02-16 1995-04-05 Thrombosis Res Inst Enzyme inhibitors
NZ302649A (en) * 1995-02-17 2000-01-28 Basf Ag Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof
US6143719A (en) * 1995-06-09 2000-11-07 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
CA2317761A1 (en) 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombin inhibitors
DE10254993A1 (de) * 2002-11-26 2004-06-09 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Säureamidarginine und deren Ester sowie deren Verwendung zur Konservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors

Also Published As

Publication number Publication date
IE56958B1 (en) 1992-02-12
WO1984003507A1 (en) 1984-09-13
EP0118280A1 (en) 1984-09-12
ES8602849A1 (es) 1985-12-01
FI844230A0 (fi) 1984-10-29
IE840474L (en) 1984-09-04
JPS60500870A (ja) 1985-06-06
AU2651684A (en) 1984-09-28
AU596783B2 (en) 1990-05-17
DK520284D0 (da) 1984-11-01
ATE44533T1 (de) 1989-07-15
DE3478928D1 (en) 1989-08-17
FI88398C (fi) 1993-05-10
ES530262A0 (es) 1985-12-01
CA1322078C (en) 1993-09-07
US4638047A (en) 1987-01-20
EP0118280B1 (en) 1989-07-12
DK520284A (da) 1984-11-01
FI88398B (fi) 1993-01-29
GB8305985D0 (en) 1983-04-07
US4772686A (en) 1988-09-20

Similar Documents

Publication Publication Date Title
FI844230L (fi) Enzyminhibition.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
KR840007569A (ko) Grf 유사체 펩티드의 제법
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
FI893833A0 (fi) Rekombinant aktivator foer naturliga doedarceller.
ES2137945T3 (es) Analogos de gnrh.
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
Kiso et al. Neo‐kyotorphin (Thr—Ser—Lys—Tyr—Arg), a new analgesic peptide
NZ511747A (en) Regulatory/unfolding peptides of ezrin
EA199900551A1 (ru) Фармацевтическая композиция, содержащая ингибитор иммуноглобулин-рецепторного взаимодействия
KR840007567A (ko) 펩티드의 제조방법
ATE46173T1 (de) Pharmakologisch aktive peptide.
JPS5283545A (en) Tri-and tetrapeptides and their derivatives
DK53290A (da) Syntetiske gaer-leader-peptider
ATE268339T1 (de) Antifungische peptide aus scleroderma texense
GB1298318A (en) Corticotropin peptides
GB1532148A (en) 1-substituted enkepholin derivatives
MX9702475A (es) Analogos del factor de crecimiento acido de fibroblasto que tienen estabilidad y acticidad biologica mejoradas.

Legal Events

Date Code Title Description
BB Publication of examined application
GB Transfer or assigment of application

Owner name: THROMBOSIS RESEARCH INSTITUTE

MM Patent lapsed
MM Patent lapsed

Owner name: THROMBOSIS RESEARCH INSTITUTE